ArticleJMIR medical informatics2026
Multi-Institutional Drug Use Patterns in Hospitalized Older Patients: Retrospective Cross-Sectional Study.
Article in JMIR medical informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundA rapidly aging population led to an increase in the number of patients with chronic diseases and polypharmacy. Although investigations on the appropriate number of drugs for older patients have been conducted, there is a shortage of studies on polypharmacy criteria in older inpatients from multiple institutions.
objectiveThe aim of this study was to examine the patterns of polypharmacy and determine the criteria for the number of drugs defining polypharmacy in the geriatric inpatient population.
methodsElectronic health records of 4 medical institutions for patients aged 65 years and older hospitalized between January 1, 2012, and December 31, 2020, were analyzed for the study. The maximum number of drugs prescribed was obtained for each patient and, along with a literature review, was used to determine the appropriate polypharmacy level for our population.
resultsWe suggest a 4-level polypharmacy category system consisting of nonpolypharmacy, polypharmacy, major polypharmacy, and excessive polypharmacy based on a review of international guidelines and polypharmacy literature. Application of this system to our study population showed that the major polypharmacy category (use of 10-19 concurrent drugs) was an appropriate threshold for polypharmacy in hospitalized patients versus the traditional threshold of 5 or more concurrent drugs. The tendency of our study population to have a higher disease and drug count supports this threshold. Frequently prescribed therapeutic subgroups in this category were antibacterials for systemic use, anesthetics, and cardiac therapy.
conclusionsThis study proposes a polypharmacy categorization system for older inpatients, which differs from the common definition of the concomitant prescription of 5 or more drugs. The older population tends to have severe conditions including those requiring major surgeries; therefore, a drug count corresponding to the definition of major polypharmacy is appropriate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.